Ajanta Pharma (BOM:532331) Interest Expense : ₹-72 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Ajanta Pharma's interest expense for the three months ended in Mar. 2024 was ₹ -15 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-72 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Ajanta Pharma's Operating Income for the three months ended in Mar. 2024 was ₹ 2,441 Mil. Ajanta Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹ -15 Mil. Ajanta Pharma's Interest Coverage for the quarter that ended in Mar. 2024 was 159.52. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ajanta Pharma Interest Expense Historical Data

The historical data trend for Ajanta Pharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Interest Expense Chart

Ajanta Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-119.10

-82.70

-102.00

-58.40

-72.10

Ajanta Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-11.30	-8.50	-23.40	-24.90	-15.30

Ajanta Pharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-72 Mil.

Ajanta Pharma (BOM:532331) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Ajanta Pharma's Interest Expense for the three months ended in Mar. 2024 was ₹-15 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹2,441 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹235 Mil.

Ajanta Pharma's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	2440.7	/	-15.3
	=	159.52

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Ajanta Pharma Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Ajanta Pharma (BOM:532331) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Interest Expense

Traded in Other Exchanges

AJANTPHARM:India

Address

Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067

Website

https://www.ajantapharma.com

Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines